HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cell cycle specificity of cytogenetic damage induced by 3,4-epoxy-1- butene.

Abstract
3,4-epoxy-1-butene (EB), a primary metabolite of butadiene, is a direct-acting "S-dependent" genotoxicant that can induce sister chromatid exchanges (SCEs) and chromosome aberrations (CAs) in cycling cells in vitro. However, EB is almost inactive when splenic or peripheral blood lymphocytes are exposed at the G(0) stage of the cell cycle. To investigate whether repair of DNA lesions is responsible for the lack of cytogenetic responses seen after G(0) treatments, we used cytosine arabinoside (ara-C) to inhibit DNA polymerization during DNA repair. If enough repairable lesions are present, double-strand breaks should accumulate and form chromosome-type ("S-independent") deletions and exchanges. This is exactly what occurred. EB induced chromosome deletions and dicentrics at the first division following treatment, when the EB exposure was followed by ara-C. Without ara-C treatment, there was no induction of CAs. These experiments indicate that the relatively low levels of damage induced by EB in G(0) lymphocytes are removed by DNA repair prior to DNA synthesis and thus, before the production of SCEs or chromatid-type aberrations.
AuthorsA D Kligerman, C L Doerr, A H Tennant
JournalMutation research (Mutat Res) Vol. 444 Issue 1 Pg. 151-8 (Jul 21 1999) ISSN: 0027-5107 [Print] Netherlands
PMID10477349 (Publication Type: Journal Article)
Chemical References
  • Epoxy Compounds
  • Mutagens
  • Cytarabine
  • 3,4-epoxy-1-butene
  • DNA
Topics
  • Cell Cycle
  • Chromosome Aberrations
  • Cytarabine (pharmacology)
  • DNA (biosynthesis, drug effects, genetics)
  • DNA Repair (drug effects)
  • Epoxy Compounds (toxicity)
  • Humans
  • In Vitro Techniques
  • Lymphocytes (cytology, drug effects, metabolism)
  • Mutagens (toxicity)
  • Resting Phase, Cell Cycle
  • Sister Chromatid Exchange (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: